Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldstein

Showing results (381-390 of 518) with videos related to

Pageof 52
Sort By:
Science (New York, N.Y.)|October 23, 2010
Detection of water in the LCROSS ejecta plumeAnthony Colaprete, Peter Schultz, Jennifer Heldmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort studyDavid Goldstein, Barbara K Bennett, Kate Webber, et al.
Circulation. Cardiovascular Quality and Outcomes|April 24, 2019
Thirty-Day Readmission Risk Model for Older Adults Hospitalized With Acute Myocardial InfarctionJohn A Dodson, Alexandra M Hajduk, Terrence E Murphy, et al.
BMC Cancer|August 20, 2021
AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancerAndrew Oar, Mark Lee, Hien Le, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group studyMartine Van Glabbeke, Jaap Verweij, Paolo G Casali, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 18, 2018
Evaluation of an online communication skills training programme for oncology nurses working with patients from minority backgroundsRajneesh Kaur, Bettina Meiser, Elvira Zilliacus, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 23, 2019
Patient-reported outcome measures (PROMs) in pancreatic cancer: a systematic reviewAshika D Maharaj, Stella Samoborec, Sue M Evans, et al.
Expert Review of Anticancer Therapy|November 5, 2021
Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international facultyMike Nguyen, Eva Segelov, David Goldstein, et al.
Oral Oncology|April 14, 2015
Extra-pulmonary small cell carcinoma in the head and neck setting: the role of prophylactic cranial irradiationMatthew Mason, Meredith Giuliani, Shao Hui Huang, et al.
Frontiers in Immunology|January 2, 2023
Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)S M Zahid Hosen, Md Nazim Uddin, Zhihong Xu, et al.
Pageof 52

Showing results (381-390 of 518) with videos related to

Sort By:
Pageof 52
Science (New York, N.Y.)|October 23, 2010
Detection of water in the LCROSS ejecta plumeAnthony Colaprete, Peter Schultz, Jennifer Heldmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort studyDavid Goldstein, Barbara K Bennett, Kate Webber, et al.
Circulation. Cardiovascular Quality and Outcomes|April 24, 2019
Thirty-Day Readmission Risk Model for Older Adults Hospitalized With Acute Myocardial InfarctionJohn A Dodson, Alexandra M Hajduk, Terrence E Murphy, et al.
BMC Cancer|August 20, 2021
AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancerAndrew Oar, Mark Lee, Hien Le, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group studyMartine Van Glabbeke, Jaap Verweij, Paolo G Casali, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 18, 2018
Evaluation of an online communication skills training programme for oncology nurses working with patients from minority backgroundsRajneesh Kaur, Bettina Meiser, Elvira Zilliacus, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 23, 2019
Patient-reported outcome measures (PROMs) in pancreatic cancer: a systematic reviewAshika D Maharaj, Stella Samoborec, Sue M Evans, et al.
Expert Review of Anticancer Therapy|November 5, 2021
Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international facultyMike Nguyen, Eva Segelov, David Goldstein, et al.
Oral Oncology|April 14, 2015
Extra-pulmonary small cell carcinoma in the head and neck setting: the role of prophylactic cranial irradiationMatthew Mason, Meredith Giuliani, Shao Hui Huang, et al.
Frontiers in Immunology|January 2, 2023
Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)S M Zahid Hosen, Md Nazim Uddin, Zhihong Xu, et al.
Pageof 52